Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy
出版年份 2018 全文链接
标题
Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy
作者
关键词
-
出版物
Nanoscale
Volume -, Issue -, Pages -
出版商
Royal Society of Chemistry (RSC)
发表日期
2018-08-28
DOI
10.1039/c8nr03899f
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles
- (2018) Yimin Niu et al. JOURNAL OF CONTROLLED RELEASE
- pH-triggered surface charge-switchable polymer micelles for the co-delivery of paclitaxel/disulfiram and overcoming multidrug resistance in cancer
- (2017) Qiang Huo et al. International Journal of Nanomedicine
- Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis
- (2017) Weijing Chu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer
- (2017) Yuanfeng He et al. JOURNAL OF CONTROLLED RELEASE
- Targeted delivery to bone and mineral deposits using bisphosphonate ligands
- (2016) Lisa E. Cole et al. ADVANCED DRUG DELIVERY REVIEWS
- Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus
- (2016) Quanyin Hu et al. ADVANCED MATERIALS
- Acid-labile boronate-bridged dextran–bortezomib conjugate with up-regulated hypoxic tumor suppression
- (2015) Weiguo Xu et al. CHEMICAL COMMUNICATIONS
- Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer
- (2015) Wei-liang Ye et al. Scientific Reports
- Tumor extracellular acidity activated “off–on” release of bortezomib from a biocompatible dendrimer
- (2015) Mingming Wang et al. Biomaterials Science
- Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging
- (2014) Jingchao Li et al. BIOMATERIALS
- Liposomal Bortezomib Nanoparticles via Boronic Ester Prodrug Formulation for Improved Therapeutic Efficacy in Vivo
- (2014) Jonathan D. Ashley et al. JOURNAL OF MEDICINAL CHEMISTRY
- Engineered nanomedicine for myeloma and bone microenvironment targeting
- (2014) A. Swami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peptide decoration of nanovehicles to achieve active targeting and pathology-responsive cellular uptake for bone metastasis chemotherapy
- (2014) Xuli Wang et al. Biomaterials Science
- Poly(ethylene glycol)–paclitaxel–alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases
- (2013) Keren Miller et al. BIOMATERIALS
- Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer
- (2012) Sanjay I. Thamake et al. BIOMATERIALS
- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
- (2011) S. Arastu-Kapur et al. CLINICAL CANCER RESEARCH
- Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
- (2011) D. Chen et al. CURRENT CANCER DRUG TARGETS
- Studies on the hemocompatibility of bacterial cellulose
- (2011) Fábia K. Andrade et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Catechol Polymers for pH-Responsive, Targeted Drug Delivery to Cancer Cells
- (2011) Jing Su et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms
- (2011) Chiara Clementi et al. MOLECULAR PHARMACEUTICS
- A Proteasome Inhibitor, Bortezomib, Inhibits Breast Cancer Growth and Reduces Osteolysis by Downregulating Metastatic Genes
- (2010) M. D. Jones et al. CLINICAL CANCER RESEARCH
- Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: anin vitroevaluation
- (2010) Wei Wei et al. Nanomedicine
- Stability of unused reconstituted bortezomib in original manufacturer vials
- (2010) Joshua P Vanderloo et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease
- (2009) Mohammad Tabrizi et al. AAPS Journal
- A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer
- (2009) Giorgio V. Scagliotti et al. LUNG CANCER
- Biodistribution and Pharmacokinetic Studies of Bone-TargetingN-(2-Hydroxypropyl)methacrylamide Copolymer−Alendronate Conjugates
- (2008) Huaizhong Pan et al. MOLECULAR PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now